The COVID-19 pandemic is likely to disproportionately impact people living with kidney disease. It is, therefore, more important than ever to monitor the care being delivered to patients with kidney diseases and to use data to advocate for those at risk of adverse outcomes.

Recognizing this, the ISN has launched several data collection initiatives over the past few months. In collaboration with the DOPPS Program team at the Arbor Research Collaborative for Health, Michigan, USA, the ISN will conduct a ‘practice patterns’ survey of the impact of COVID-19 on hemodialysis and peritoneal dialysis programs around the world.

The survey will be offered worldwide via the ten ISN Regional Boards.

Countries currently active within the DOPPS program will not need to repeat the survey; their data will be combined with the other countries to produce a global picture.

To discover more about ISN’s collaboration with DOPPS, please visit our website.